⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3298156 | 0.78 | — | — | |
| SCHEMBL3701364 | 0.78 | — | — | |
| SCHEMBL1512953 | 0.71 | — | — | |
| SCHEMBL29016 | 0.71 | — | — | |
| SCHEMBL9005288 | 0.71 | — | — | |
| SCHEMBL165 | 0.71 | — | — | |
| SCHEMBL9526624 | 0.67 | CA1 (0.57) | — | |
| SCHEMBL4232558 | 0.63 | CA1 (0.80) | — | |
| SCHEMBL1774535 | 0.63 | CA1 (0.80) | — | |
| SCHEMBL461657 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113358865-B | Method for detecting circulating tumor cells | 深圳先进技术研究院 | 2024-06-04 | — | — | CN | claimed |
| CN-110283222-B | Positron imaging agent 18 F-FPGalNAc and preparation method and application thereof | 南方医科大学南方医院 | 2022-08-30 | — | — | CN | claimed |
| CN-110041390-B | Method for synthesizing On-DNA 1,2, 3-triazole compound in DNA coding compound library | 上海药明康德新药开发有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-109369755-B | Positron imaging agent of targeting ASGPR (advanced persistent receptor-induced gpropy), and preparation method and application thereof | 南方医科大学南方医院 | 2022-03-04 | — | — | CN | claimed |
| CN-112321436-A | Method for synthesizing heteroatom-substituted aromatic compound from styrene compound | 北京大学 | 2021-02-05 | — | — | CN | claimed |
| WO-2025086855-A1 | AZIDE PRODRUG COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 中科帅天医药(深圳)有限公司 | 2025-05-01 | — | — | WO | disclosed |
| CN-119552125-A | Compounds and compositions for ocular treatment | 艾弗德罗股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119325477-A | Process for the preparation of 1- [ 5-tert-butyl-3- [ (1-methyltetrazol-5-yl) methyl ] triazolo [4,5-d ] pyrimidin-7-yl ] pyrrolidin-3-ol | 豪夫迈·罗氏有限公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-113677658-B | Flow synthesis method for producing oseltamivir | 纳尔逊·曼德拉大学 | 2024-12-10 | — | — | CN | disclosed |
| CN-114072149-B | Compounds and compositions for ocular treatment | 艾弗德罗股份有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-110167944-B | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors | 联合疗法公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-118284606-A | Bicyclic amine derivatives as GABAA α5 receptor modulators | 吉瑞工厂 | 2024-07-02 | — | — | CN | disclosed |
| EP-1634876-A2 | Heterocyclic compounds for the treatment of hyperlipidemia agents | Nippon Shinyaku Co., Ltd. (JP) | 2006-03-15 | — | — | EP | disclosed |
| US-6998412-B2 | Heterocyclic compounds | NIPPON SHINYAKU CO., LTD. (JP) | 2006-02-14 | — | — | US | disclosed |
| US-20050009892-A1 | Heterocyclic compounds | NIPPON SHINYAKU CO., LTD. (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20050009785-A1 | Heterocyclic compounds | KUWABARA KENJI (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20040162325-A1 | Heterocyclic compounds | KUWABARA KENJI (JP) | 2004-08-19 | — | — | US | disclosed |
| US-20030166697-A1 | Heterocyclic compounds | NIPPON SHINYAKU CO., LTD. (JP) | 2003-09-04 | — | — | US | disclosed |
| WO-2003051898-A1 | UNUSUAL NUCLEOSIDE LIBRARIES, COMPOUNDS, AND PREFERRED USES AS ANTIVIRAL AND ANTICANCER AGENTS | RIBAPHARM INC. (US) | 2003-06-26 | — | — | WO | disclosed |
| EP-1295875-A1 | HETEROCYCLIC COMPOUNDS | Nippon Shinyaku Co., Ltd. (JP) | 2003-03-26 | — | — | EP | disclosed |